March 14, 2023
A twist of fate led to regenerative medicine
A chance meeting on a student shuttle bus put Wenchun Qu, M.D., Ph.D., on a new direction that years later would culminate in becoming the Jorge and Leslie Bacardi Associate Director of the Mayo Clinic Center for Regenerative Biotherapeutics in Florida. During a ride to the University of Southern California (USC) where Dr. Qu was […]
Tags: #cell therapy, #Dr. Wenchun Qu, #gene therapy, #Mayo Clinic Center for Regenerative Biotherapeutics, #physical medicine & rehabilitation, #stem cell research
January 5, 2023
Expanding regenerative biotherapeutics to new practice areas
As a physician at the forefront of new cancer therapies, Yi Lin, M.D., Ph.D., understands the highs and lows that patients experience. Will the latest technologies slow or stop disease? If not, is this the last, best option? Dr. Lin, a hematologist, sees the need for a new class of drugs that provides different treatment […]
Tags: #cancer immunotherapies, #CAR T-cell therapy, #Dr. Yi Lin, #gene therapy, #Mayo Clinic Center for Regenerative Biotherapeutics, #tissue engineeering
September 27, 2022
Julie Allickson, Ph.D. on Mayo Clinic Q&A Podcast
Through research, clinical trials and biomanufacturing, Mayo Clinic’s Center for Regenerative Biotherapeutics is working to develop new types of medicines derived from the human body to treat chronic and age-related diseases. Biologics are therapies that come from human sources — cells, blood, enzymes, tissues, genes or genetically engineered cells — for use in medicines. Biomanufacturing is focused on […]
Tags: #3D printing, #Biomanufacturing, #Cancer, #cell therapy, #Dr. Julie Allickson, #gene therapy, #Mayo Clinic Center for Regenerative Biotherapeutics
August 15, 2022
Mayo Clinic announces a strategic collaboration for a new era of biomanufacturing
Mayo Clinic today announced a strategic collaboration in biomanufacturing to deliver novel biotherapeutics for rare and complex conditions. The collaboration brings together science, engineering and manufacturing to advance Mayo Clinic’s vision of bringing new cures to clinical care. The focus will be on therapies derived from human sources known as biologics — cells, blood, enzymes, […]
Tags: #biologics, #cell therapy, #Dr. Julie Allickson, #gene therapy, #Mayo Clinic Center for Regenerative Medicine, #National Resilience Inc.